APA

Minami M., Driscoll E. M., Simpson P. J., Hoff P. T. & Lucchesi B. R. (19950421). Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. : Pharmacology.

Chicago

Minami M, Driscoll E M, Simpson P J, Hoff P T and Lucchesi B R. 19950421. Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. : Pharmacology.

Harvard

Minami M., Driscoll E. M., Simpson P. J., Hoff P. T. and Lucchesi B. R. (19950421). Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. : Pharmacology.

MLA

Minami M, Driscoll E M, Simpson P J, Hoff P T and Lucchesi B R. Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. : Pharmacology. 19950421.